The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Safety and Tolerability of Methylphenidate in Preschool Children With ADHD
Abstract
Objective To report on the safety and tolerability of methylphenidate (MPH) 3- to 5-year-old children with attention-deficit/hyperactivity disorder (ADHD) during 1 year of treatment.Method Exactly 183 children (3-5 years old) entered a treatment study of MPH, consisting of a 1-week open-label lead-in (n=183); a 5-week placebo-controlled, double-blind phase (n=165); a 5-week double-blind, parallel phase (n=114); and 10 months of open-label maintenance (n=140 entered, 95 completed). Mean total daily MPH doses rose from the titration trial best dose, 14.1 (+/-8.1) mg/day, to 20.5 (+/-9.7) mg/day mean total daily dose at the end of maintenance. Pulse, blood pressure, and the presence of treatment emergent adverse events (AEs), parent and teacher AE ratings, and vital signs were recorded in each phase.Results Thirty percent of parents spontaneously reported moderate to severe AEs in all study phases after baseline. These included emotional outbursts, difficulty falling asleep, repetitive behaviors/thoughts, appetite decrease, and irritability. During titration, decreased appetite (chi=5.4, p<.03), trouble sleeping (chi=5.4, p<.03), and weight loss (chi=4.0, p<.05) occurred statistically more often on MPH than on placebo. During maintenance, trouble sleeping and appetite loss persisted and other MPH-related AEs decreased. There were transient, one-time pulse and blood pressure elevations in five children. Twenty-one children (11%) discontinued because of drug-attributed AEs.Conclusions Eleven percent of preschoolers discontinued treatment because of intolerable MPH AEs. Of the serious AEs reported, one occurred in baseline, two in lead-in, three in titration, one in parallel, and one in maintenance. Only one was possibly related to MPH.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a substantial number of children experience notable side effects with stimulant medication (MTA Cooperative Group, 2004; Swanson et al., 2006; Swanson et al., 2007a; Wigal et al., 2006)”
From The influences of environmental enrichment, cognitive enhancement, and physical exercise on brain development: Can we alter the developmental trajectory of ADHD? (2011) · cites this paper as Wigal et al., 2006
Citations
Cites
(1976) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1976.tb115280.x · Cited by 5,225
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
Sissman, N. J. (2000) · JAMA · doi:10.1001/jama.284.3.369 · Cited by 862
Barkley, R. A., McMurray, M. B., EDELBROCK, C. S., & Robbins, K. (1990) · PEDIATRICS · doi:10.1542/peds.86.2.184 · Cited by 481
Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD
GREENHILL, L., KOLLINS, S., ABIKOFF, H., MCCRACKEN, J., RIDDLE, M., SWANSON, J., MCGOUGH, J., WIGAL, S., WIGAL, T., VITIELLO, B., et al. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000235077.32661.61 · Cited by 467
Barkley, R. A., McMurray, M. B., EDELBROCK, C. S., & Robbins, K. (1990) · PubMed · Cited by 433
Medication treatment strategies in the MTA Study: relevance to clinicians and researchers
GREENHILL, L. L., ABIKOFF, H. B., ARNOLD, L. E., CANTWELL, D. P., CONNERS, C. K., ELLIOTT, G., HECHTMAN, L., HINSHAW, S. P., HOZA, B., JENSEN, P. S., et al. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199610000-00017 · Cited by 297
Hyperactivity in preschoolers and the effect of methylphenidate.
Schleifer, M., Weiss, G., Cohen, N. J., Elman, M., Cvejic, H., & Kruger, E. (1975) · American Journal of Orthopsychiatry · doi:10.1111/j.1939-0025.1975.tb01164.x · Cited by 234
Nelson textbook of pediatrics, 16th ed.
Behrman, R. E. (2000) · Cited by 219
Pharmacotherapy for Children with Attention-Deficit Hyperactivity Disorder
Pelham, W. E. (1993) · School Psychology Review · doi:10.1080/02796015.1993.12085647 · Cited by 207
Research works printed but not linked: 1
- Greenhill, 2001, Preschool ADHD Treatment Study (PATS): science and controversy, Economics Neurosci, 3, 49
Cited by
Sorted by citations
Items 201–242 of 242
Classification of ADHD Using Heterogeneity Classes and Attention Network Task Timing
Hanson, S. E. (2018) · VTechWorks (Virginia Tech) · Cited by 1
Anderson, L. M., & Phelps, L. (2009) · doi:10.1002/9781118269602.ch19 · Cited by 1
ADHD: Culture, Treatment Strategies and their Relevance to Preschool Children
Bean, N. M. (2010) · Scholarship - Claremont (Claremont Colleges)
Hierro, R. S., Herrero, M. J. P., Diago, C. C., & Casas, A. M. (2013) · Revista de Neurología · doi:10.33588/rn.56s01.2012664
Early screening and identification of preschool children affected by serious emotional disorders
Robey-Williams, C. R. (2014) · Scholar Commons (University of South Carolina)
Bower, B. (2006) · Science News · doi:10.2307/4017562
Purushothaman, P. (2013) · Child and Adolescent Psychopharmacology News · doi:10.1521/capn.2013.18.4.1
Rational Use of Medication in Preschool Age Children
Dave, B. (2012) · Child and Adolescent Psychopharmacology News · doi:10.1521/capn.2012.17.4.8
Kim, E.-J. (2011) · Journal of korean Academy of Child and Adolescent Psychiatry · doi:10.5765/jkacap.2011.22.2.074
Lumu, L. (2014) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg)
Eizaguirre, M. Á. V., Aróstegui, J. A. I., & de Salud, S. N. (2014)
A Developmental Perspective on Attention-Defity Disorder (ADHD)
Campbell, S. B. G., Halperin, J. M., & Sonuga-Barke, E. J. S. (2014)
The ADHD Clinic: a collaborative model of care.
Campbell, L. A., & Allan, C. C. (2014) · Europe PMC (PubMed Central)
Evidence-based pharmacotherapy of attention deficit hyperactivity disorder
Vaughan, B. S., March, J. S., & Kratochvil, C. J. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511910395.002
Graham, J. M., Seth, S., & Coghill, D. (2007)
Simone, A. N. (2017) · CUNY Academic Works (City University of New York)
Psychopharmacology: Special Considerations When Working with Young Children
Barterian, J. A. (2019) · Pediatric school psychology · doi:10.1007/978-3-030-15541-4_10
Vitiello, B. (2021) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2021.05.011
Ünal, D., Nalbant, K., Ünal, D., & Aybı, M. (2021) · Turkish Journal of Pediatric Disease · doi:10.12956/tchd.864959
(2009) · Wiley eBooks · doi:10.1002/9780470684382.refs
Posner, J. E., Greenhill, L. L., & Nelson, J. C. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch108
Advances in Pharmacological Treatment of Pediatric Obesity
Goran, M. I. (2016) · CRC Press eBooks · doi:10.1201/9781315370958-31
(2016) · Wiley eBooks · doi:10.1002/9781118972519.refs
(2012) · CRC Press eBooks · doi:10.1201/b13357-95
Current awareness: Pharmacoepidemiology and drug safety
(2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1374
(2010) · Wiley eBooks · doi:10.1002/9781444328172.refs
Current awareness in human psychopharmacology
(2007) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.793
(2015) · Elsevier eBooks · doi:10.1016/b978-0-444-53717-1.01067-2
Sugaya, L. S. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2023.tde-20062023-124723
Blum, N. J., Justine Shults, A., Barbaresi, W. J., Bax, A. C., Cacia, J., Deavenport‐Saman, A., Friedman, S., Loe, I. M., Mittal, S., Vanderbilt, D. L., et al. (2023) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000001209
“A large randomized controlled trial, the Preschool ADHD Treatment Study (PATS), found that methylphenidate can be effective in preschool ADHD, although responses are variable and adverse effects are common.(7,8) Alpha-2 adrenergic agonists (A2As) or atomoxetine has been recommended if stimulants (STIM) are not effecti…”
BackgroundAmendola, S., Fanizza, I., Scoditti, S., Rinaldis, M. D., & Trabacca, A. (2023) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-023-01560-2
“It follows that intellectual disability and rule-breaking behaviour may interact with side effects and these patients experience increased irritability with drug treatment [52], or they could perceive side effects as more distressing, both leading to treatment discontinuation.”
BackgroundChapter 66. Treatment of Autism Spectrum Disorder
Hegarty, J. P., & Hardan, A. Y. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as66
Therapeutic Use of Dopamine Enhancers (Stimulants)
Zuddas, A., & Carucci, S. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_138
Psychopharmacology Considerations for Children Aged under 6 Years
Romanowicz, M., Pease, E. R., Tarikogullari, I., PON, N. C., & Gleason, M. M. (2025) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2024.08.003
(2025) · Wiley eBooks · doi:10.1002/9781118941430.refs
Long-term Safety of Stimulant Medications: Used to Treat Children with ADHD
Lerner, M., & Wigal, T. L. (2008) · Pediatric Annals · doi:10.3928/0090-4481-20080101-05
Rashidi, Y., Barjasteh, A. H., Ilaghi, M., Pozvei, A., Soltanpour, M., Jahangiri, S., Radmanesh, M., Pourbafrani, A., Faegh, S. H. H., Bagheri, F., et al. (2026) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2026.102741
“These side effects can negatively impact the overall quality of life in children undergoing MPH therapy [199,200].”
Attention-Deficit/Hyperactivity Disorder
(2026) · American Academy of PediatricsItasca, IL eBooks · doi:10.1542/9781610029223-ch12
Levine, B. H. (2008)
Posner, K., Pressman, A. W., & Greenhill, L. L. (2010) · Elsevier eBooks · doi:10.1016/b978-84-458-2021-6.00003-8
Metadata
- Authors
- WIGAL, T., GREENHILL, L., CHUANG, S., McGOUGH, J., VITIELLO, B., SKROBALA, A., SWANSON, J., WIGAL, S., ABIKOFF, H., KOLLINS, S., McCRACKEN, J., RIDDLE, M., POSNER, K., GHUMAN, J., DAVIES, M., THORP, B., & STEHLI, A.
- Affiliations
- University of Arizona (US)
- Corresponding author
- GREENHILL, LAURENCE
- ORCID
- Venue
- Journal of the American Academy of Child & Adolescent Psychiatry
- Publisher
- Elsevier BV
- Published
- 2006-11
- Volume
- 45
- Issue
- 11
- Pages
- 1294-1303
- ISSN
- 0890-8567 (ISSN-L)
- OpenAlex
- W2046668977
- Cited by
- 242
- References
- 25
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 4 · 2023: 13 · 2022: 6 · 2021: 7 · 2020: 6 · 2019: 9 · 2018: 8 · 2017: 7 · 2016: 14 · 2015: 10 · 2014: 14 · 2013: 15 · 2012: 16
- FWCI
- 13.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of the American Academy of Child & Adolescent Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Funders
- National Institute of Mental Health (U01 MH 60943, U01 MH60900, K23MH001883, U01MH060903, U01 MH60833, U01MH060900, U01MH060848, U01MH060642, U01 MH 60642, U01 MH60903, U01MH060833, U01MH060943, U01 MH60848)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Keywords
- methylphenidate, attention deficit hyperactivity disorder, preschool children, drug safety, tolerability, adverse events, sleep disorders, appetite loss, weight loss, treatment discontinuation, blood pressure, pulse rate
- MeSH terms
- Central Nervous System Stimulants, Anorexia, Attention Deficit Disorder with Hyperactivity, Child, Preschool, Double-Blind Method, Female, Humans, Male, Methylphenidate, Sleep Wake Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review